These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15035228)

  • 1. [The role of PPAR gamma for the osteoblastic differentiation].
    Takeda S; Takeuchi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():789-93. PubMed ID: 15035228
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in basic research of bone metabolism].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Function of nuclear receptors in bone remodeling and formation].
    Kato S
    Tanpakushitsu Kakusan Koso; 2008 Jun; 53(7):854-62. PubMed ID: 18536348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adhesion molecules in the context with bone remodeling and osteoporosis].
    Tanaka Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
    [No Abstract]   [Full Text] [Related]  

  • 5. The function of nuclear receptors in bone tissues.
    Kato S; Suzawa M; Takada I; Takeyama K; Yanagizawa J; Fujiki R; Kitagawa H
    J Bone Miner Metab; 2003; 21(6):323-36. PubMed ID: 14586788
    [No Abstract]   [Full Text] [Related]  

  • 6. [PPAR gamma: a major nuclear receptor in adipogenesis].
    Gervois P; Fruchart JC
    Med Sci (Paris); 2003 Jan; 19(1):20-2. PubMed ID: 12836187
    [No Abstract]   [Full Text] [Related]  

  • 7. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells.
    Diascro DD; Vogel RL; Johnson TE; Witherup KM; Pitzenberger SM; Rutledge SJ; Prescott DJ; Rodan GA; Schmidt A
    J Bone Miner Res; 1998 Jan; 13(1):96-106. PubMed ID: 9443795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PPAR (peroxisome proliferator activated receptor), a factor that decides differentiation of adipocytes].
    Sakaguchi K; Morita I; Murota S
    Kokubyo Gakkai Zasshi; 1997 Sep; 64(3):458. PubMed ID: 9424474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Switching of osteoblastogenesis versus adipogenesis].
    Takada I
    Clin Calcium; 2012 May; 22(5):629-36. PubMed ID: 22549186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crosstalk between the immune and skeletal system].
    Takayanagi H
    Ryumachi; 2003 Oct; 43(4):624-31. PubMed ID: 14598653
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications.
    Nuttall ME; Gimble JM
    Curr Opin Pharmacol; 2004 Jun; 4(3):290-4. PubMed ID: 15140422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the regulation of bone remodeling].
    Matsumoto T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PPAR family (PPAR alpha, PPAR delta, PPAR gamma)].
    Kamon J; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():593-600. PubMed ID: 12238104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S; Kiyokawa A; Nagayama Y
    Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat's loss is bone's gain.
    Pei L; Tontonoz P
    J Clin Invest; 2004 Mar; 113(6):805-6. PubMed ID: 15067310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).
    Duque G; Macoritto M; Kremer R
    Exp Gerontol; 2004 Mar; 39(3):333-8. PubMed ID: 15036392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LPS].
    Miyaura C
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():116-9. PubMed ID: 15035108
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
    J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.